Human Genome Sciences (HGS) is a biopharmaceutical company with world-class R&D and manufacturing facilities and a newly created commercial team based in Rockville, MD. We have recently received appr...
Human Genome Sciences (HGS) is a biopharmaceutical company with world-class R&D and manufacturing facilities and a newly created commercial team based in Rockville, MD. We have recently received approval for our first commercial product; and currently have several other products in the pipeline undergoing clinical trials. At Human Genome Sciences, people are the key to our success. We share a passion for scientific and business innovation, creating unique opportunities to contribute to the commercialization phase of our products. Human Genome Sciences exists to place new therapies into the hands of those battling serious disease. We believe that solving critical medical challenges takes more than hopes and dreams. It takes careful planning, relentless resilience, the best scientific minds, and rigorous clinical trials. Success will come, but it will come by design. We commit ourselves to that daily struggle, working systematically to achieve breakthrough results one careful step at a time.
Founded Year
1992
Organization Website
hgsi.com
Organization Languages
English
Organization Revenue
300000
Current Technologies
addthis
mobile friendly
google tag manager
ensighten
new relic
asp net
outlook
postini
route 53
easydns
amazon aws
adobe cq
google dynamic remarketing
google analytics
peoplefluent
google adsense
facebook widget
google adwords conversion
doubleclick
doubleclick conversion
flxone
twitter advertising
youtube
google universal analytics
facebook login
facebook web custom audiences
Job Functions
Support
Human Resources
Engineering
Information Technology
Education
Operations
Sales
Administrative
Media And Commmunication
Accounting
Legal
Consulting
Marketing
Product Management
Finance
mab
biopharmaceutical
biotechnology
health care
medical
health
wellness & fitness
Kate Desantis's Work History and Education
Human Genome Sciences
Director, Investor Relations and Corporate Communications